Spire Healthcare Group (LON:SPI) Stock Price Down 18.1% – Time to Sell?

Spire Healthcare Group plc (LON:SPI) shares fell 18.1% on Thursday . The stock traded as low as GBX 169 ($2.18) and last traded at GBX 183.95 ($2.37). 8,024,729 shares changed hands during mid-day trading, an increase of 1,005% from the average session volume of 726,218 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 4.3 %

The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The firm has a market capitalization of £724.61 million, a PE ratio of 25.68, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The firm has a 50-day moving average of GBX 228.24 and a two-hundred day moving average of GBX 230.26.

Spire Healthcare Group (LON:SPI) last issued its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.